← SynDRA
DICLOXACILLIN
SynDRA canonical compound SYN0002444 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | bacterial cell wall synthesis inhibitor |
| Indication | gram-positive bacterial infections |
| Disease area | infectious disease |
All known targets
- ABCB11
- CHRM1
- CHRM2
- CHRM3
- HRH2
- PBP2
- PDE2A
- SLC6A3
- mecA
- pbp4
- pbpA
- pbpF
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- pbp4 INHIBITOR
- mecA INHIBITOR
- pbpA INHIBITOR
- PBP2 INHIBITOR
- pbpF INHIBITOR
Drug classes
- Penicillin-class Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01C · BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Cross-references
Synonyms
- dicloxacycline
- dicloxacillin sodium
- dicloxacillin sodium hydrate
- dicloxacillin sodium monohydrate
- Dicloxacilline
- Dicloxacilina
- BRL-1702
- R-13423
- Dichloroxacillin
- Diclossacillina
- Dicloxaciclin
- Dicloxacilin
- Dicloxacillinum
- Dicloxacycline
- Dycill
- Dynapen
- Maclicine
- Methyldichlorophenylisoxazolylpenicillin
- Pathocil
- Diclossacillina [DCIT]
- Dicloxacillin sodium
- BRL 1702
- Diclocil (TN)
- Dicloxacilina [INN-Spanish]
- Dicloxacilline [INN-French]
- Dicloxacillinum [INN-Latin]
- Dicloxacillin (USAN/INN)
- Dicloxacillin [USAN:INN:BAN]
- Dicloxacillin, Monosodium Salt, Mono-Hydrate
- (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin
- 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
- 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid
- 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid
- R 13423
- COF19H7WBK
Reported adverse events
- Hepatotoxicity
- Nausea
- Eosinophilia
- Pseudomembranous colitis
- Agranulocytosis
Look up DICLOXACILLIN in the interactive SynDRA portal →